Eperisone Hydrochloride is applied in addressing symptoms related to increased neurological or muscular activity. It may assist with the overall symptom burden for conditions characterized by periods of heightened symptoms, such as muscle stiffness and spasticity.

The medication is commonly used to help with symptoms that create noticeable physiological strain and is considered relevant for use in situations involving various musculoskeletal disorders and spastic paralysis. It helps address symptom clusters that may become intense or disruptive, and contributes to improved comfort during periods of heightened symptoms.

Eperisone is considered relevant for use in situations involving cervical syndrome, periarthritis of the shoulder, low back pain, and spastic paralysis. It is relevant for easing symptoms that become more disruptive during flare-ups and is applied in scenarios where additional management of discomfort is required. The key areas of use include symptoms associated with cervical syndrome, periarthritis of the shoulder, low back pain, and conditions resulting in spastic paralysis.

It assists with maintaining functional stability and supports the patient during difficult episodes by easing distress. As part of supportive symptomatic management, it provides support that helps ease the overall symptom burden.

---

Quick Fact: Supportive Management for Muscle Spasticity and Tension

Regulatory References

1. cervical syndrome, periarthritis of the shoulder, low back pain, and spastic paralysis

Eperisone Hydrochloride KN is intended for use in adult patients, with dosage typically adjusted based on age and symptom severity. Official documents define specific populations who must not use this medicine or must use it with caution.

Contraindicated and Restricted Populations

The medicine is contraindicated for any patient with a known allergy or hypersensitivity to eperisone hydrochloride or its ingredients.

Use is Not Recommended:

• Pediatric Use: Safety and effectiveness have not been established in patients under 18 years of age, and its use is not recommended in this group.
• Pregnancy: Use is not recommended in pregnant women or women who may be pregnant unless the expected therapeutic benefit is determined to outweigh the possible risks.
• Lactation: Use is not recommended in breastfeeding women. If treatment is deemed necessary, breastfeeding should be discontinued for the duration of therapy.

Use Requires Caution (Special Consideration):

• Elderly Patients: Caution is advised, as the elderly often have impaired physiological functions. Dose reduction and close monitoring may be required.
• Hepatic Impairment: The drug should be used with care in patients with liver function disorders, as it may aggravate hepatic dysfunction.

Patients who experience side effects such as lassitude, light-headedness, or drowsiness must have their dosage reduced or treatment discontinued.

Interactions with other medicines and products

The official interaction profile for Eperisone Hydrochloride KN emphasizes specific constraints related to pharmacodynamic effects and substance co-consumption, as documented in regulatory information. All interaction details are presented at a high, regulatory-aligned descriptive level, strictly based on official government sources.

Documented Drug-Drug Interactions

Co-administration with certain other centrally acting muscle relaxants should be avoided due to a documented pharmacodynamic interaction. Specifically, combining Eperisone with Tolperisone Hydrochloride or Methocarbamol increases the risk of disturbances in ocular accommodation (impaired visual focusing), a reason for restricting their concurrent use.

Interacting Substance	Official Interaction Outcome	Restriction Classification
Tolperisone Hydrochloride, Methocarbamol	Increased risk of disturbances in ocular accommodation	Use should be avoided

Substance and Population Constraints

Official regulatory documents contain mandatory restrictions regarding substance intake and population-specific cautions:

• Alcohol: Official labeling mandates that consumption of alcohol must be stopped while using Eperisone. This constraint is in place to avoid potential aggravation of hepatic side effects.
• Food: The medicine is recommended to be taken after meals. While this is an administration rule to mitigate potential gastrointestinal discomfort, it acts as a timing constraint.
• Hepatic Impairment: Caution is required in patients with disorders of liver function, as official sources state the medicine may aggravate hepatic dysfunction. This represents a population-specific risk related to potentially altered clearance.

How Eperisone Hydrochloride KN Works

Eperisone Hydrochloride functions through a distinct dual mechanism involving both the central nervous system and peripheral vascular system to modulate muscle tone and associated physiological input.

---

Modulating Central Spinal Reflexes

The molecule acts as a centrally acting agent by suppressing the activity of the spinal reflex arc. Its mechanism involves preferentially inhibiting the firing of gamma (gamma)-motor neurons in the spinal cord. This action reduces the sensitivity of muscle spindles, which are sensory organs that mediate muscle contraction, thereby decreasing the nerve signals that mediate excessive muscle contraction.

---

Ion Channel Blockade and Vascular Relaxation

Eperisone achieves its dual effect through molecular interference, primarily involving the blockade of voltage-gated sodium ( Na^+) and calcium ( Ca^2+) channels. In nerve cells, this ion blockade stabilizes the neuronal membrane to limit signal propagation and neurotransmitter release, supporting the spinal inhibition effect. In vascular smooth muscle, the Ca^2+ channel antagonism and weaker alpha-adrenergic receptor antagonism relax the vascular smooth muscle. This promotes vasodilation, which increases local blood flow and perfusion to the muscle tissue, acting in concert with the central action.

The use of Eperisone Hydrochloride KN tablets follows a standard administration protocol for this oral medication.

Official Administration Protocol

The table below summarizes the key administration parameters:

Parameter	Standard Instruction (Adults)
Route of Administration	Oral
Standard Dosing Schedule	50 mg per dose, 3 times a day
Timing in Relation to Meals	Take immediately after each meal
Procedural Condition	Swallow the tablet whole (do not chew or crush)
Dosage Adjustment Rule	The dosage should be adjusted according to age, symptoms, or condition
Age-Group Rule	Reduced dosage and careful monitoring are recommended for elderly patients
Missed-Dose Rule	Skip the missed dose if it is almost time for the next dose; do not take two doses at once

The overall procedural structure dictates that adults maintain a three-times-daily frequency, taking one tablet following each of the main meals to ensure standardized timing. Adherence to this protocol includes swallowing the tablet whole and only allowing a healthcare professional to adjust the standard 150 mg daily total dosage. The instructions provide a clear, non-doubling rule for managing missed doses.

Overview of Clinical Research

Eperisone Hydrochloride has been the subject of multiple clinical trials, primarily focusing on its application as a centrally acting muscle relaxant for muscle spasm and associated pain. The primary research areas include acute low back pain (LBP) and painful conditions involving muscle stiffness, such as cervical spondylosis.

---

Efficacy and Study Findings

Clinical evidence for Eperisone Hydrochloride largely stems from randomized, controlled trials (RCTs) and comparative studies:

• Acute Low Back Pain (LBP): Studies in patients with acute musculoskeletal spasm associated with LBP have compared eperisone to placebo over short treatment periods (e.g., 14 days). Research has reported that the eperisone group demonstrated greater improvements in functional outcomes, such as the finger-to-floor distance (a measure of spinal flexion), compared to the placebo group.
• Comparison to Other Muscle Relaxants: Comparative studies have been conducted evaluating eperisone against other muscle relaxants (e.g., tizanidine, thiocolchicoside) in the treatment of LBP. Findings generally suggest that the drugs explored exhibited comparable effects on pain reduction and muscle relaxation. However, one study noted eperisone had a lower reported incidence of adverse effects and drowsiness compared to diazepam.
• Combination Therapy: Research has explored the use of eperisone in combination with non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen. Some findings suggest that the combination was associated with greater pain reduction and functional improvement compared to the NSAID alone in patients with acute non-specific back pain and muscle spasm.

---

Safety Profile and Pharmacokinetics

Eperisone's safety profile has been tracked in clinical settings. The most common adverse effects reported in trials include mild gastrointestinal symptoms, headache, and dizziness. Studies monitoring the drug's absorption suggest it is rapidly absorbed following oral administration.

Specific trials have also focused on monitoring for potential adverse events, particularly in comparison to other muscle relaxants.

Common questions about Eperisone Hydrochloride KN (FAQ)

---

Q: What medical conditions is Eperisone prescribed to treat?

Official information indicates Eperisone is used for the improvement of muscle tension associated with conditions such as cervical syndrome, frozen shoulder (shoulder periarthritis), and low back pain. It is also utilized to help manage spastic paralysis linked to disorders like cervical spondylosis and cerebral vascular disorder.

---

Q: What should I do if I experience a severe or allergic reaction to Eperisone?

If symptoms of a serious adverse reaction, such as shock, severe allergic symptoms (anaphylactoid symptoms, like hives or difficulty breathing), or severe skin disorders (like SJS/TEN) occur, official guidance indicates that the medicine should be stopped immediately. Seeking urgent medical attention is advised.

---

Q: Why can't I take Eperisone with Tolperisone Hydrochloride or Methocarbamol?

Official product information restricts the use of Eperisone with other centrally acting muscle relaxants, specifically Tolperisone or Methocarbamol. This constraint is in place to avoid an increased risk of disturbances in ocular accommodation. This term refers to a specific problem with visual focusing.

---

Q: Can Eperisone be crushed or split to make it easier to swallow?

Official administration instructions specify that the tablet must be swallowed whole. The regulatory documents explicitly state that the tablet should not be chewed or crushed to ensure it is administered correctly.

---

Q: How long does it take for Eperisone Hydrochloride KN to start working after I take it?

Studies included in the regulatory review indicate that the medicine is rapidly absorbed following oral administration. The concentration of the drug in the blood typically reaches its peak level approximately 1.6 hours after a dose is taken.

---

Q: What are the official instructions for how to throw away unused Eperisone?

Official safety information includes instructions that patients are advised to discard any remainder of the medicine and not to store it for future use. For the proper disposal procedure, individuals are directed to ask a pharmacist or medical institution.

How to Store and Dispose of Eperisone Hydrochloride KN

The storage and disposal of Eperisone Hydrochloride tablets are governed by official regulatory instructions to ensure product stability and safety.

Required Storage Conditions

The medicine must be stored away from direct sunlight, heat, and moisture. For public safety, it is required to keep Eperisone Hydrochloride out of the reach of children, aligning with official labeled instructions.

Handling and Disposal Instructions

Official patient information dictates specific rules for unused medication. Patients must discard the remainder of the medicine and are explicitly instructed not to store them for future use. Furthermore, unused product must not be given to others. For proper disposal procedures, individuals are directed to ask the pharmacist or medical institution how to discard the product.